Advanced Enzyme Technologies Ltd

Advanced Enzyme Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Advanced Enzyme Technologies Ltd

₹ 360 -0.07%
18 Apr 4:01 p.m.
advancedenzymes.com BSE: 540025 NSE : ADVENZYMES
About

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Key Points

Market Position
The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]

Website BSE NSE
  • Market Cap ₹ 4,017 Cr.
  • Current Price ₹ 360
  • High / Low ₹ 425 / 250
  • Stock P/E 32.8
  • Book Value ₹ 49.7
  • Dividend Yield 1.11 %
  • ROCE 14.9 %
  • ROE 11.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 18.3%

Cons

  • Stock is trading at 7.23 times its book value
  • Promoter holding has decreased over last quarter: -2.30%
  • The company has delivered a poor sales growth of 8.00% over past five years.
  • Company has a low return on equity of 13.2% over last 3 years.
  • Earnings include an other income of Rs.58.4 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
79 71 73 65 64 71 72 77 80 83 85 97 91
52 49 46 47 51 55 61 58 58 59 61 70 67
Operating Profit 27 22 26 18 13 15 11 19 21 23 25 27 25
OPM % 34% 31% 36% 27% 20% 22% 16% 25% 27% 28% 29% 28% 27%
2 3 1 2 1 5 1 2 4 3 51 1 4
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 3 2 2 2 3 2 3 3 3 3 3 3
Profit before tax 26 22 25 17 12 18 10 18 22 23 73 25 25
Tax % 23% 31% 26% 26% 26% 20% 24% 26% 25% 25% 8% 26% 25%
20 15 19 13 9 14 8 14 17 18 67 18 19
EPS in Rs 1.82 1.36 1.66 1.15 0.78 1.28 0.70 1.22 1.49 1.56 6.04 1.64 1.71
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
112 141 135 125 139 173 212 222 247 283 273 312 356
82 101 107 91 103 124 162 169 170 183 200 236 256
Operating Profit 30 39 28 34 36 48 50 53 77 101 73 76 99
OPM % 27% 28% 21% 27% 26% 28% 24% 24% 31% 36% 27% 24% 28%
3 2 1 1 1 6 5 6 9 7 9 9 58
Interest 4 4 8 5 4 3 3 3 1 0 0 0 0
Depreciation 5 7 9 8 7 8 8 9 9 9 10 10 11
Profit before tax 25 31 12 23 25 44 44 47 76 98 72 74 147
Tax % 12% 30% 16% 14% 18% 21% 18% 25% 24% 28% 24% 25%
22 21 10 20 21 35 36 35 58 71 55 56 122
EPS in Rs 2.10 1.97 0.91 1.81 1.92 3.10 3.22 3.16 5.19 6.36 4.88 4.97 10.95
Dividend Payout % 10% 15% 11% 6% 10% 13% 16% 19% 12% 14% 21% 20%
Compounded Sales Growth
10 Years: 8%
5 Years: 8%
3 Years: 8%
TTM: 19%
Compounded Profit Growth
10 Years: 10%
5 Years: 9%
3 Years: -1%
TTM: 134%
Stock Price CAGR
10 Years: %
5 Years: 13%
3 Years: 0%
1 Year: 44%
Return on Equity
10 Years: 13%
5 Years: 14%
3 Years: 13%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 21 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 61 107 116 134 152 233 267 297 348 413 458 503 534
75 61 59 38 49 38 45 18 10 1 2 2 2
35 43 31 28 37 25 39 38 42 53 48 48 61
Total Liabilities 192 233 228 223 261 318 373 376 423 490 530 576 619
48 114 110 106 101 98 98 97 127 132 132 143 147
CWIP 59 0 2 5 7 8 10 7 10 7 9 11 9
Investments 14 28 28 27 53 103 120 120 121 184 189 201 244
71 91 88 84 99 108 145 151 165 166 200 220 218
Total Assets 192 233 228 223 261 318 373 376 423 490 530 576 619

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
25 18 18 33 22 21 23 35 46 84 37 50
-40 -28 -7 -7 -27 -55 -22 -2 -25 -70 -14 -42
8 8 -11 -27 4 34 -1 -33 -19 -15 -11 -12
Net Cash Flow -7 -2 -0 -1 -0 -0 -0 -0 2 -1 12 -4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 92 87 77 71 60 65 66 63 77 70 66 78
Inventory Days 203 304 363 389 393 300 234 249 245 240 295 228
Days Payable 176 151 90 74 75 50 90 66 56 85 75 54
Cash Conversion Cycle 119 240 350 386 378 316 210 246 265 226 286 252
Working Capital Days 84 120 112 126 142 153 114 120 138 110 142 132
ROCE % 20% 20% 10% 14% 14% 18% 15% 15% 21% 24% 15% 15%

Shareholding Pattern

Numbers in percentages

10 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
52.30% 52.55% 52.71% 52.70% 52.70% 49.88% 49.88% 49.88% 46.52% 45.92% 43.62% 43.50%
16.40% 16.27% 16.39% 18.01% 18.72% 21.68% 21.74% 21.86% 21.89% 22.27% 22.54% 23.01%
8.46% 8.66% 8.99% 6.90% 6.26% 5.60% 5.64% 5.73% 7.58% 6.49% 6.98% 7.56%
22.84% 22.52% 21.91% 22.38% 22.32% 22.86% 22.76% 22.54% 24.02% 25.34% 26.88% 25.95%
No. of Shareholders 79,25487,11284,34686,57384,37684,27781,18377,53775,05272,64273,03468,640

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls